X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
male (50) 50
female (49) 49
aged (47) 47
index medicus (43) 43
middle aged (37) 37
cardiac & cardiovascular systems (36) 36
treatment outcome (30) 30
cardiovascular (24) 24
stents (23) 23
aged, 80 and over (19) 19
cardiology and cardiovascular medicine (18) 18
japan (18) 18
peripheral vascular disease (18) 18
prospective studies (18) 18
risk factors (18) 18
angioplasty (17) 17
drug-eluting stents (16) 16
follow-up studies (16) 16
time factors (16) 16
vascular patency (14) 14
percutaneous coronary intervention (13) 13
peripheral arterial disease - therapy (13) 13
cardiology (12) 12
adult (11) 11
patients (11) 11
prosthesis design (11) 11
retrospective studies (11) 11
stent (11) 11
surgery (11) 11
acute coronary syndrome (9) 9
drug-eluting stent (9) 9
femoral artery - diagnostic imaging (9) 9
implantation (9) 9
kaplan-meier estimate (9) 9
peripheral artery disease (9) 9
prasugrel (9) 9
restenosis (9) 9
abridged index medicus (8) 8
clopidogrel (8) 8
coronary angiography (8) 8
endovascular therapy (8) 8
femoral artery - physiopathology (8) 8
intervention (8) 8
lesions (8) 8
proportional hazards models (8) 8
recurrence (8) 8
registries (8) 8
analysis (7) 7
artery-disease (7) 7
coronary artery disease (7) 7
coronary artery disease - therapy (7) 7
endovascular procedures - adverse effects (7) 7
endovascular procedures - instrumentation (7) 7
paclitaxel - administration & dosage (7) 7
balloon angioplasty (6) 6
bare-metal stents (6) 6
cardiovascular disease (6) 6
care and treatment (6) 6
clinical trials (6) 6
constriction, pathologic (6) 6
coronary heart disease (6) 6
diabetes mellitus (6) 6
disease (6) 6
follow-up (6) 6
mortality (6) 6
multivariate analysis (6) 6
peripheral arterial disease - diagnostic imaging (6) 6
peripheral arterial disease - physiopathology (6) 6
popliteal artery - diagnostic imaging (6) 6
superficial femoral artery (6) 6
superficial femoral-artery (6) 6
thrombosis (6) 6
acute myocardial-infarction (5) 5
angiography (5) 5
coronary vessels (5) 5
double-blind method (5) 5
heart attacks (5) 5
hospitals (5) 5
impact (5) 5
ischemia (5) 5
medicine & public health (5) 5
myocardial infarction - mortality (5) 5
myocardial infarction - therapy (5) 5
myocardial-infarction (5) 5
nitinol stent (5) 5
outcomes (5) 5
paclitaxel (5) 5
paclitaxel-eluting stent (5) 5
platelet aggregation inhibitors - therapeutic use (5) 5
popliteal artery (5) 5
prognosis (5) 5
revascularization (5) 5
risk (5) 5
safety (5) 5
severity of illness index (5) 5
ticlopidine - analogs & derivatives (5) 5
transluminal angioplasty (5) 5
trial (5) 5
alloys (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 6, pp. 790 - 796
Abstract It has not been established whether the achievement of optimal medical therapy (OMT) before implantation of a drug-eluting stent has a clinical... 
Cardiovascular | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | STATIN THERAPY | AMERICAN-COLLEGE | PREVENTION | BLOOD-PRESSURE CONTROL | ISCHEMIC-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | INTERVENTION | ASSOCIATION | Blood Pressure | Prospective Studies | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Hypertension - drug therapy | Male | Dyslipidemias - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Percutaneous Coronary Intervention - methods | Cholesterol, LDL - blood | Female | Hypertension - epidemiology | Antineoplastic Agents, Phytogenic - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hypoglycemic Agents - therapeutic use | Drug-Eluting Stents | Dyslipidemias - drug therapy | Sirolimus - therapeutic use | Risk Reduction Behavior | Japan | Diabetes Mellitus - drug therapy | Proportional Hazards Models | Diabetes Mellitus - metabolism | Paclitaxel - therapeutic use | Randomized Controlled Trials as Topic | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Dyslipidemias - epidemiology | Antibiotics, Antineoplastic - therapeutic use | Diabetes Mellitus - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged | Coronary Artery Disease - epidemiology | Angiotensin Receptor Antagonists - therapeutic use | Transluminal angioplasty | Medical colleges | Care and treatment | Analysis | Patient outcomes | Low density lipoproteins | Cardiac patients | Glycosylated hemoglobin | Cardiology | Coronary heart disease | Stent (Surgery) | Cardiovascular agents | Medical research | Medicine, Experimental | Heart attacks | Medical treatment | Cardiovascular disease | Desserts | Multivariate analysis | Clinical outcomes | Studies | Confidence intervals | Variables | Body mass index | Coronary vessels | Diabetes | Stents | Logistics
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 1, pp. 16 - 23
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2017, Volume 66, Issue 1, pp. 130 - 142.e1
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 739 - 748
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2016, Volume 65, Issue 3, pp. 720 - 725
Abstract Background Cilostazol improves clinical endovascular therapy outcomes for femoropopliteal (FP) lesions in patients with symptomatic peripheral... 
Surgery | SURGERY | ZILVER PTX | METAANALYSIS | THERAPY | ANTITHROMBOTIC DRUG | IMPLANTATION | SAFETY | RANDOMIZED-TRIAL | PERIPHERAL VASCULAR DISEASE | INTERVENTION | Recurrence | Prospective Studies | Constriction, Pathologic | Humans | Middle Aged | Male | Peripheral Arterial Disease - complications | Popliteal Artery - drug effects | Prosthesis Design | Endovascular Procedures - instrumentation | Time Factors | Popliteal Artery - physiopathology | Tetrazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Female | Registries | Odds Ratio | Paclitaxel - administration & dosage | Ultrasonography, Doppler, Duplex | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Endovascular Procedures - adverse effects | Femoral Artery - physiopathology | Japan | Risk Factors | Paclitaxel - adverse effects | Logistic Models | Treatment Outcome | Femoral Artery - drug effects | Popliteal Artery - diagnostic imaging | Vascular Patency - drug effects | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Propensity Score | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnostic imaging | Aged | Tetrazoles - adverse effects | Cardiovascular Agents - adverse effects | Cardiology | Medical colleges | Stent (Surgery) | Diagnostic imaging
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 12, pp. 1189 - 1198
Abstract Objectives The NIPPON (Nobori Dual Antiplatelet Therapy as Appropriate Duration) study was a multicenter randomized investigation of the... 
Cardiovascular | dual antiplatelet therapy | net adverse clinical and cerebrovascular event(s) | biodegradable polymer | stent thrombosis | drug-eluting stent(s) | net adverse clinical and erebrovascular event(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RISK | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | PREDICTORS | CLINICAL-TRIALS | COMPLICATIONS | DURATION | Myocardial Infarction - mortality | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Prosthesis Design | Aspirin - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Acute Coronary Syndrome - complications | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Stroke - mortality | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Japan | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Absorbable Implants | Stroke - etiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Acute Coronary Syndrome - diagnosis | Intention to Treat Analysis | Acute Coronary Syndrome - therapy | Clopidogrel | Polymers - chemistry | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article